Replies to post #186778 on Biotech Values

[DewDiligence]

MYL acquires women’s health business from India’s FamY Care for $750M cash plus $50M in contingent payments:

http://finance.yahoo.com/news/mylan-acquire-famy-care-businesses-114400549.html

[DewDiligence]

EpiPen provides 40% of MYL’s operating income, according to Bloomberg:

http://www.bloomberg.com/news/articles/2015-09-23/how-marketing-turned-the-epipen-into-a-billion-dollar-business

The 40% figure must refer to MYL as it existed before its “spinversion” with ABT.

[DewDiligence]

ABT has sold 77% of its original (Jan 2015) MYL holding—and now owns 25.8M shares (a 4.8% stake):

https://www.sec.gov/Archives/edgar/data/1800/000110465917018990/a17-9815_1sc13da.htm

Since ABT’s stake in MYL is now <5%, no further reports on Form 13D will need to be filed.